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Background
Chronic infection with hepatitis B virus (HBV) induces
transregulation of the host cell gene expression and even-
tually malignant transformation. HBV X protein acts as a
transactivator of cellular promoters leading to upregula-
tion of DNA methyltransferases and alterations of DNA
methylation patterns.
Aim of the study
To contribute to our understanding of DNA and chro-
matin-modifying mechanisms modulated by HBV, which
are responsible for the transregulation of host cells for
virus particle production and malignant transformation
of hepatocytes. We further study the effect of lamivudine
treatment or an antiviral vector-based RNAi strategy tar-
geting HBx on the establishment and maintenance of
DNA methylation patterns. Our research not only aims
to uncover epigenomic plasticity modulated by HBV. We
also intend to contribute to the open problem, whether
therapies lead to the restoration of regular epigenomic
signatures, or whether hepatocytes persist in a deregu-
lated epigenetic ‘memory’ state of HBV infection thus
still carrying the risk for malignant transformation.
Methods
Therefore we analyze expression profiles by qRT PCR
arrays. DNA methylation as well as chromatin signatures
of genes up- or downregulated upon HBV infection are
studied by MeDIP or ChIP respectively, in murine cell
lines infected with HBV.
Results
We identified several transregulated genes and monitored
DNA methylation and chromatin signatures at selected
loci within promoters. Moreover we observed that thera-
peutic strategies lead to changes in the epigenomic signa-
ture of hepatocytes.
Conclusions
Our data show that our experimental therapeutic interven-
tions efficiently suppress HBV proliferation, whereas an
increased risk of malignant transformation cannot be
excluded.
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